{"entity":{"type":"insider","cik":"0001608601","url":"/insider/0001608601","json_url":"/insider/0001608601.json","name":"Bowden Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":22,"first":"2015-06-02","last":"2021-06-22","span_basis":"filed_date"},"name_variants":[{"name":"Bowden Christopher","source":"filing","n_filings":22,"first_seen":"2015-06-02","last_seen":"2021-06-22"}],"transactions":[{"id":5103888,"accession":"0001439222-21-000059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-21-000059","line_url":"/filing/0001439222-21-000059#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48493.0,"shares_display":"48,493","price_per_share":60.1087,"price_display":"60.11","price_state":"stated","total_value":2914851.1891,"total_display":"2,914,851.19","total_whole":"2,914,851","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-22","scope":"insider"},{"id":4599690,"accession":"0001439222-21-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000058","line_url":"/filing/0001439222-21-000058#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2502.0,"shares_display":"2,502","price_per_share":60.0198,"price_display":"60.02","price_state":"stated","total_value":150169.5396,"total_display":"150,169.54","total_whole":"150,170","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider"},{"id":5359626,"accession":"0001439222-21-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-21-000057","line_url":"/filing/0001439222-21-000057#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20853.0,"shares_display":"20,853","price_per_share":60.0603,"price_display":"60.06","price_state":"stated","total_value":1252437.4359,"total_display":"1,252,437.44","total_whole":"1,252,437","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":5359620,"accession":"0001439222-21-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000057","line_url":"/filing/0001439222-21-000057#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7149.0,"shares_display":"7,149","price_per_share":60.1646,"price_display":"60.16","price_state":"stated","total_value":430116.7254,"total_display":"430,116.73","total_whole":"430,117","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":5222132,"accession":"0001439222-21-000056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-21-000056","line_url":"/filing/0001439222-21-000056#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6675.0,"shares_display":"6,675","price_per_share":60.0657,"price_display":"60.07","price_state":"stated","total_value":400938.5475,"total_display":"400,938.55","total_whole":"400,939","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider"},{"id":5222125,"accession":"0001439222-21-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000056","line_url":"/filing/0001439222-21-000056#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4268.0,"shares_display":"4,268","price_per_share":60.0357,"price_display":"60.04","price_state":"stated","total_value":256232.3676,"total_display":"256,232.37","total_whole":"256,232","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":4916259,"accession":"0001439222-21-000036","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001439222-21-000036","line_url":"/filing/0001439222-21-000036#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14401.0,"shares_display":"14,401","price_per_share":55.106,"price_display":"55.11","price_state":"stated","total_value":793581.506,"total_display":"793,581.51","total_whole":"793,582","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-21","scope":"insider"},{"id":4916253,"accession":"0001439222-21-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-21-000036","line_url":"/filing/0001439222-21-000036#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3210.0,"shares_display":"3,210","price_per_share":55.1572,"price_display":"55.16","price_state":"stated","total_value":177054.612,"total_display":"177,054.61","total_whole":"177,055","shares_owned_after":15487.0,"shares_owned_after_display":"15,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider"},{"id":2313339,"accession":"0001439222-20-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-20-000041","line_url":"/filing/0001439222-20-000041#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3583.0,"shares_display":"3,583","price_per_share":50.014,"price_display":"50.01","price_state":"stated","total_value":179200.162,"total_display":"179,200.16","total_whole":"179,200","shares_owned_after":8306.0,"shares_owned_after_display":"8,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider"},{"id":2846503,"accession":"0001439222-20-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-20-000008","line_url":"/filing/0001439222-20-000008#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7100.0,"shares_display":"7,100","price_per_share":50.1566,"price_display":"50.16","price_state":"stated","total_value":356111.86,"total_display":"356,111.86","total_whole":"356,112","shares_owned_after":1650.0,"shares_owned_after_display":"1,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-18","scope":"insider"},{"id":2492262,"accession":"0001439222-20-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-20-000006","line_url":"/filing/0001439222-20-000006#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":50.0213,"price_display":"50.02","price_state":"stated","total_value":31063.2273,"total_display":"31,063.23","total_whole":"31,063","shares_owned_after":1650.0,"shares_owned_after_display":"1,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-13","scope":"insider"},{"id":2094269,"accession":"0001439222-20-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-20-000005","line_url":"/filing/0001439222-20-000005","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49638.0,"shares_display":"49,638","price_per_share":50.082372617752526,"price_display":"50.08","price_state":"stated","total_value":2485988.812,"total_display":"2,485,988.81","total_whole":"2,485,989","shares_owned_after":1650.0,"shares_owned_after_display":"1,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider","n_lines":2},{"id":7978102,"accession":"0001209191-19-023072","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-023072","line_url":"/filing/0001209191-19-023072","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":66.574672,"price_display":"66.57","price_state":"stated","total_value":665746.72,"total_display":"665,746.72","total_whole":"665,747","shares_owned_after":11384.0,"shares_owned_after_display":"11,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider","n_lines":4},{"id":7868009,"accession":"0001209191-19-020288","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-020288","line_url":"/filing/0001209191-19-020288","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":64.1615,"price_display":"64.16","price_state":"stated","total_value":641615.0,"total_display":"641,615.00","total_whole":"641,615","shares_owned_after":8538.0,"shares_owned_after_display":"8,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-19","scope":"insider","n_lines":2},{"id":6079503,"accession":"0001209191-18-049065","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-049065","line_url":"/filing/0001209191-18-049065#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":80.03,"price_display":"80.03","price_state":"stated","total_value":136051.0,"total_display":"136,051.00","total_whole":"136,051","shares_owned_after":924.0,"shares_owned_after_display":"924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-30","filed_date":"2018-08-31","scope":"insider"},{"id":6079499,"accession":"0001209191-18-049065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-049065","line_url":"/filing/0001209191-18-049065#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","total_whole":"24,000","shares_owned_after":924.0,"shares_owned_after_display":"924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-29","filed_date":"2018-08-31","scope":"insider"},{"id":6017551,"accession":"0001209191-18-042453","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-042453","line_url":"/filing/0001209191-18-042453","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":86.756,"price_display":"86.76","price_state":"stated","total_value":173512.0,"total_display":"173,512.00","total_whole":"173,512","shares_owned_after":1724.0,"shares_owned_after_display":"1,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-12","scope":"insider","n_lines":2},{"id":6706593,"accession":"0001209191-18-037724","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-037724","line_url":"/filing/0001209191-18-037724","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":92.893,"price_display":"92.89","price_state":"stated","total_value":185786.0,"total_display":"185,786.00","total_whole":"185,786","shares_owned_after":1081.0,"shares_owned_after_display":"1,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-14","scope":"insider","n_lines":2},{"id":6199728,"accession":"0001209191-18-030184","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-030184","line_url":"/filing/0001209191-18-030184","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":85.0014,"price_display":"85.00","price_state":"stated","total_value":170002.8,"total_display":"170,002.80","total_whole":"170,003","shares_owned_after":881.0,"shares_owned_after_display":"881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-11","filed_date":"2018-05-15","scope":"insider","n_lines":2},{"id":6861896,"accession":"0001209191-18-029223","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-029223","line_url":"/filing/0001209191-18-029223#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":81.38,"price_display":"81.38","price_state":"stated","total_value":162760.0,"total_display":"162,760.00","total_whole":"162,760","shares_owned_after":881.0,"shares_owned_after_display":"881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-08","filed_date":"2018-05-10","scope":"insider"},{"id":6290768,"accession":"0001209191-18-024967","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-024967","line_url":"/filing/0001209191-18-024967","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":85.095,"price_display":"85.10","price_state":"stated","total_value":170190.0,"total_display":"170,190.00","total_whole":"170,190","shares_owned_after":1581.0,"shares_owned_after_display":"1,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-12","filed_date":"2018-04-16","scope":"insider","n_lines":2},{"id":6015946,"accession":"0001209191-18-020231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-020231","line_url":"/filing/0001209191-18-020231","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":82.3305,"price_display":"82.33","price_state":"stated","total_value":164661.0,"total_display":"164,661.00","total_whole":"164,661","shares_owned_after":1181.0,"shares_owned_after_display":"1,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-16","scope":"insider","n_lines":2},{"id":6517876,"accession":"0001209191-18-011244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-011244","line_url":"/filing/0001209191-18-011244","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":77.6525,"price_display":"77.65","price_state":"stated","total_value":155305.0,"total_display":"155,305.00","total_whole":"155,305","shares_owned_after":1381.0,"shares_owned_after_display":"1,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-20","scope":"insider","n_lines":2},{"id":6757588,"accession":"0001209191-18-007532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-007532","line_url":"/filing/0001209191-18-007532","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":78.750025,"price_display":"78.75","price_state":"stated","total_value":157500.05,"total_display":"157,500.05","total_whole":"157,500","shares_owned_after":1566.0,"shares_owned_after_display":"1,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider","n_lines":2},{"id":4832931,"accession":"0001209191-17-052627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052627","line_url":"/filing/0001209191-17-052627#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":390000.0,"total_display":"390,000.00","total_whole":"390,000","shares_owned_after":881.0,"shares_owned_after_display":"881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-11","filed_date":"2017-09-13","scope":"insider"},{"id":8093695,"accession":"0001209191-15-049125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049125","line_url":"/filing/0001209191-15-049125#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001608601","owner_name":"Bowden Christopher","owner_display_name":"Bowden Christopher","owner_url":"/insider/0001608601","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":120.67,"price_display":"120.67","price_state":"stated","total_value":603350.0,"total_display":"603,350.00","total_whole":"603,350","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Medical Officer)","n_filings":22,"first_seen":"2015-06-02","last_seen":"2021-06-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001608601","retrieved_at":"2026-08-22T16:05:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}